Product
L04TD2
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Randomized, Open-label, Single-dose, Two-sequence, Two-period, Crossover Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of L04TD2 and L04RD1 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-11-01